Women can now assess their breast cancer risk with the help of AI
General Washington
Archived
•
October 25, 2026
•
Everlywell will offer patients access to Clairity Breast, an AI tool approved by the FDA to predict a woman’s five-year risk of breast cancer based on imaging.
Source: Seattle Times WA | https://www.seattletimes.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



